CABG: The Gold Standard or Is There Room to Excel?
media
posted on 2020-03-12, 21:57 authored by Faisal Ghazi Bakaeen, Joseph F. Sabik, Michael E. Farkouh, Joanna Chikwe, Mario F. L. GaudinoFilmed at the 2020 STS Annual Meeting in New Orleans, Louisiana, Faisal Ghazi Bakaeen of the Cleveland Clinic in Ohio, USA, moderates a discussion on coronary artery bypass grafting (CABG). Dr Bakaeen is joined by Joseph F. Sabik of the University Hospitals Cleveland Medical Center in Ohio, USA; Michael E. Farkouh of the University of Toronto in Canada; Joanna Chikwe of Cedars-Sinai Smidt Heart Institute in Los Angeles, California; and Mario F. L. Gaudino of Weill Cornell Medicine in New York City. They discuss the controversies surrounding the EXCEL trial, other recent trials comparing CABG vs. percutaneous coronary intervention, and ways to improve CABG, with a specific emphasis on the use of multiarterial grafting.
Disclosures
Dr Sabik serves on the Cardiac Surgery Advisory Board for Medtronic.
Dr Farkouh has received research grants from Amgen, Novartis, and Novo Nordisk.
Dr Chikwe serves as speaker, consultant, and course organizer for Edwards Lifesciences and Medtronic.
Disclaimer
The information and views presented on CTSNet.org represent the views of the authors and contributors of the material and not of CTSNet. Please review our full disclaimer page here.